Find clinical trials for Endometrial Cancer in Toronto, ON
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Endometrial Cancer trials near Toronto, ON, CAN:
The RAINBO umbrella program consists of four clinical trials investigating new adjuvant therapies in endometrial cancer patients. E ...
Phase 2, Phase 3
Toronto, Canada and 13 other locations
This is a phase 2 study of investigational drug niraparib and TSR-042 in patients with advanced/recurrent endometrial cancer. The p ...
Phase 2
Toronto, Ontario, Canada and 6 other locations
study to evaluate the efficacy and safety of dostarlimab versus carboplatin-paclitaxel in patients with MMR deficient relapse or advanced endometrial...
Phase 3
Toronto, Canada and 58 other locations
(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...
Phase 3
Toronto, Ontario, Canada and 202 other locations
for maintenance selinexor in participants with advanced or recurrent endometrial cancer. Participants with primary stage IV or recu...
Phase 3
Toronto, Ontario, Canada and 77 other locations
participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....
Phase 3
Toronto, Ontario, Canada and 162 other locations
choice (doxorubicin or paclitaxel) for the treatment of advanced endometrial cancer. Participants will be randomly assigned to rece...
Phase 3
Toronto, Ontario, Canada and 168 other locations
antigen (HLA) and MAGE-A4 tumor antigen. Tumor indications include endometrial, esophageal, esophagogastric junction (EGJ), gastric, head an....
Phase 1
Toronto, Ontario, Canada and 21 other locations
durvalumab (MEDI4736) in patients with relapsed gynaecological cancers to assess the response in groups of patients selected based on their ...
Phase 2
Toronto, Ontario, Canada and 8 other locations
to other places in the body, it is called advanced or metastatic cancer. Participants in this study must have head and neck squamous cell ca ...
Phase 2
Toronto, Ontario, Canada and 30 other locations
Clinical trials
Research sites
Resources
Legal